Legal Representation
Attorney
Lisa C. Pavento
USPTO Deadlines
Next Deadline
1310 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-02-28)
Due Date
February 28, 2029
Grace Period Ends
August 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
48 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 28, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Feb 28, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jan 26, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Jan 25, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Jan 18, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Jan 4, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jan 4, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jul 9, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 8, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jun 28, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jun 28, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 6, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 4, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jan 4, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jan 4, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 17, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Dec 17, 2021 | EWOR | I | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | Loading... |
Dec 17, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Dec 17, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jul 16, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 15, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jul 6, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jul 6, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 13, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 12, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Dec 22, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Dec 22, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 5, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 4, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Aug 4, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jul 7, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 7, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 7, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Nov 12, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 12, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 23, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 4, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
Oct 1, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 30, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 28, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 28, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 29, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 29, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 29, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 20, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 8, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 19, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Services in the field of molecular biology, namely, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds and tumor antigens with pharmaceutical properties; development of test methods and test kits in the field of molecular biology; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumor therapy; development of tumor markers; development of diagnostic and therapeutic antibodies; genetic and biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific purposes
First Use Anywhere:
Sep 29, 2016
First Use in Commerce:
Sep 29, 2016
Classification
International Classes
042